# A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia

> **NCT02570152** · NA · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 2004 (actual)

## Conditions studied

- Dengue

## Interventions

- **PROCEDURE:** Blood sample collection

## Key facts

- **NCT ID:** NCT02570152
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-01
- **Primary completion:** 2019-06-28
- **Final completion:** 2019-06-28
- **Target enrollment:** 2004 (ACTUAL)
- **Last updated:** 2020-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02570152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02570152, "A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02570152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*